Get my own profile
Public access
View all4 articles
6 articles
available
not available
Based on funding mandates
Co-authors
- Clive PrestidgeProfessor, Co-Director Centre for Pharmaceutical Innovation,University of South AustraliaVerified email at unisa.edu.au
- Nicky ThomasAdjunct Senior Research Fellow, University of South Australia, School of Pharmacy and MedicalVerified email at unisa.edu.au
- Claus-Michael LehrHelmholtz Inst. Pharm. Research Saarland (HIPS)Verified email at helmholtz-hzi.de
- Ben J. BoydMonash Institute of Pharmaceutical SciencesVerified email at monash.edu
- P. Lynne HowellThe Hospital for Sick ChildrenVerified email at sickkids.ca
- Xabier MurgiaBiochemist, Cruces University HospitalVerified email at helmholtz-hzi.de
- Benjamin ThierryProfessor of Bionegineering, University of South AustraliaVerified email at unisa.edu.au
- Katharina RichterUniversity of AdelaideVerified email at adelaide.edu.au
- Daniel WozniakOhio State UniversityVerified email at osumc.edu
- Andrew J. ClulowSenior Beamline Scientist - BioSAXS, ANSTO Australian SynchrotronVerified email at ansto.gov.au
- Zlatko KopeckiAcademic Research Fellow, University of South AustraliaVerified email at unisa.edu.au
- Mohammed Al-HawwasUniversity of South AustraliaVerified email at unisa.edu.au
- Manasi Mantri JambhrunkarUniversity of south AustraliaVerified email at uq.edu.au
Follow
Chelsea R. Thorn
Senior Scientist, Biotherapeutics Formulations at Pfizer Inc.
Verified email at pfizer.com